Zimmer Biomet Valuation
| ZBH Stock | USD 110.73 1.05 0.94% |
At this time, the company appears to be undervalued. Zimmer Biomet Holdings maintains a prevalent Real Value of $116.45 per share. The last-minute price of the company is $110.73. Our model calculates the value of Zimmer Biomet Holdings from examining the company fundamentals such as Profit Margin of 0.12 %, current valuation of 27.72 B, and Return On Asset of 0.0465 as well as analyzing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Zimmer Biomet's valuation include:
Price Book 1.7679 | Enterprise Value | Enterprise Value Ebitda 12.3157 | Price Sales 2.8706 | Forward PE 13.4771 |
Undervalued
Today
Please note that Zimmer Biomet's price fluctuation is very steady at this time. Calculation of the real value of Zimmer Biomet Holdings is based on 3 months time horizon. Increasing Zimmer Biomet's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Zimmer Biomet is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Zimmer Stock. However, Zimmer Biomet's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 110.73 | Real 116.45 | Target 124.5 | Hype 110.97 | Naive 108.07 |
The intrinsic value of Zimmer Biomet's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Zimmer Biomet's stock price.
Estimating the potential upside or downside of Zimmer Biomet Holdings helps investors to forecast how Zimmer stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Zimmer Biomet more accurately as focusing exclusively on Zimmer Biomet's fundamentals will not take into account other important factors: When choosing an evaluation method for Zimmer Biomet Holdings, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using all methods to arrive at a better estimate.
Zimmer Biomet Cash |
|
Zimmer Valuation Trend
Zimmer Biomet's real value analysis enables investors to forecast the earnings more efficiently. Using both Zimmer Biomet's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing decisions.
Zimmer Revenue by Product
Zimmer Biomet Total Value Analysis
Zimmer Biomet Holdings is at this time forecasted to have company total value of 27.72 B with market capitalization of 22.04 B, debt of 6.2 B, and cash on hands of 375.7 M. Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the Zimmer Biomet fundamentals before making security assessment based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
27.72 B | 22.04 B | 6.2 B | 375.7 M |
Zimmer Biomet Investor Information
About 94.0% of the company outstanding shares are owned by institutional investors. The company has Price to Book (P/B) ratio of 1.77. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Zimmer Biomet Holdings has Price/Earnings To Growth (PEG) ratio of 1.51. The entity last dividend was issued on the 31st of March 2025. The firm had 103:100 split on the 1st of March 2022. Based on the key indicators related to Zimmer Biomet's liquidity, profitability, solvency, and operating efficiency, Zimmer Biomet Holdings may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Profit Margin | 0.22 | 0.1674 |
|
| |||||
| Total Cash From Operating Activities | 1.1 B | 1.5 B |
|
| |||||
| Operating Income | 873.8 M | 1.3 B |
|
|
Zimmer Biomet Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Zimmer Biomet has an asset utilization ratio of 35.94 percent. This signifies that the Company is making $0.36 for each dollar of assets. An increasing asset utilization means that Zimmer Biomet Holdings is more efficient with each dollar of assets it utilizes for everyday operations.Zimmer Biomet Ownership Allocation
Zimmer Biomet Holdings retains a total of 199.06 Million outstanding shares. The majority of Zimmer Biomet outstanding shares are owned by institutional investors. These institutions are usually referred to as non-private investors looking to purchase positions in Zimmer Biomet Holdings to benefit from reduced commissions. Consequently, other corporate entities are subject to a different set of regulations than regular investors in Zimmer Biomet Holdings. Please pay attention to any change in the institutional holdings of Zimmer Biomet Holdings as this could imply that something significant has changed or is about to change at the company. Please note that on March 13, 2025, Representative Julie Johnson of US Congress acquired under $15k worth of Zimmer Biomet Holdings's common stock.Zimmer Biomet Profitability Analysis
The company reported the last year's revenue of 7.68 B. Total Income to common stockholders was 452.4 M with profit before taxes, overhead, and interest of 5.5 B.Zimmer Biomet Past Distributions to stockholders
About Zimmer Biomet Valuation
An absolute valuation paradigm, as applied to Zimmer Stock, attempts to find the value of Zimmer Biomet Holdings based on its fundamental and basic technical indicators. By analyzing Zimmer Biomet's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Zimmer Biomet's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Zimmer Biomet. We calculate exposure to Zimmer Biomet's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Zimmer Biomet's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 5.5 B | 3.7 B | |
| Pretax Profit Margin | 0.13 | 0.20 | |
| Operating Profit Margin | 0.17 | 0.22 | |
| Net Profit Margin | 0.12 | 0.15 | |
| Gross Profit Margin | 0.71 | 0.80 |
Zimmer Biomet Quarterly Retained Earnings |
|
A single share of Zimmer Biomet represents a small ownership stake in the entity. As a stockholder of Zimmer, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.
Zimmer Biomet Dividends Analysis For Valuation
As of now, Zimmer Biomet's Dividends Paid is decreasing as compared to previous years. The Zimmer Biomet's current Dividend Yield is estimated to increase to 0.02, while Dividend Payout Ratio is projected to decrease to 0.21. . The Zimmer Biomet's current Price Earnings Ratio is estimated to increase to 35.21, while Retained Earnings are projected to decrease to under 7 B.
| Last Reported | Projected for Next Year | ||
| Dividends Paid | 196 M | 200.6 M | |
| Dividend Yield | 0.01 | 0.02 | |
| Dividend Payout Ratio | 0.22 | 0.21 | |
| Dividend Paid And Capex Coverage Ratio | 2.71 | 4.90 |
There are various types of dividends Zimmer Biomet can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of Zimmer shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from Zimmer Biomet Holdings directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When Zimmer pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of Zimmer Biomet by the value of the dividends paid out.
Zimmer Biomet Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 203.9 M | |
| Quarterly Earnings Growth Y O Y | -0.405 | |
| Forward Price Earnings | 13.4771 |
Zimmer Biomet Current Valuation Indicators
Valuation refers to the process of determining the present value of Zimmer Biomet Holdings and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Zimmer we look at many different elements of the entity such as Zimmer's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Zimmer Biomet, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Zimmer Biomet's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Zimmer Biomet's worth.Complementary Tools for Zimmer Stock analysis
When running Zimmer Biomet's price analysis, check to measure Zimmer Biomet's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zimmer Biomet is operating at the current time. Most of Zimmer Biomet's value examination focuses on studying past and present price action to predict the probability of Zimmer Biomet's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zimmer Biomet's price. Additionally, you may evaluate how the addition of Zimmer Biomet to your portfolios can decrease your overall portfolio volatility.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |